# A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer

> **NCT07711067** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **ElmediX** · enrollment: 95 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (mPDAC)
- Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

## Interventions

- **DEVICE:** Whole-body hyperthermia
- **DRUG:** Standard-of-Care Systemic therapy

## Key facts

- **NCT ID:** NCT07711067
- **Lead sponsor:** ElmediX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2030-03-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2026-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711067, "A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*